Multidisciplinary weight-loss program

Multidisciplinary weight-loss program has been studied in 2 papers since 2024: 2 trials in people. The newest paper, Sep 4, 2024: “Muscle Strength and Phase Angle Are Potential Markers for the Efficacy of Multidisciplinary Weight-Loss Program in Patients with Sarcopenic Obesity”.

Intervention

2 papers study it6 findingsUpdated

See all 2 papers on multidisciplinary weight-loss program

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“When implementing the model by including the dichotomous variable SMMI delta changes instead of the variable HGS, we found that the interaction was not statistically significant (p-value = 0.2563).”
Muscle Strength and Phase Angle Are Potential Markers for the Efficacy of Multidisciplinary Weight-Loss Program in Patients with Sarcopenic ObesityJournal of clinical medicine2024doi:10.3390/jcm13175237

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • Funder: Italian Government Ministry of Health
  • Human trial2

Studies in people

2 studies gave multidisciplinary weight-loss program to people and measured what changed.

What changedDesignPeopleSource

down: Lowers the risk of sarcopenic obesity42.6% (n = 80) out of 188 SO patients at admission resulted in not being sarcopenic

no change: Has no effect on muscle mass

Trial4 weeks2,004 people62% female patientsmean age of 56 (±14) yearsPatients admitted for diagnostic evaluation and a 4-week multidisciplinary rehabilitation program aimed at addressing obesityJournal of clinical medicine, Sep 4, 2024

down: Decreases body weightmedian 11.7 kg (range 0-33)

up: Increases liver transplant eligibility8 transplanted and 4 waitlisted of 19 patients

Treated cohortAugust 2019 to September 202319 people18 years or olderHigh BMI liver transplant candidatesTransplantation, May 17, 2024

What did studies of multidisciplinary weight-loss program find?

4

Studies of multidisciplinary weight-loss program measured 4 outcomes, among them muscle mass, muscle mass and liver transplant eligibility.

Muscle mass

no changein humans1

1 study
  1. Multidisciplinary weight-loss program showed no clear effect on muscle mass in logistic regression model for No SO state.

    “When implementing the model by including the dichotomous variable SMMI delta changes instead of the variable HGS, we found that the interaction was not statistically significant (p-value = 0.2563).”

    Human trialin logistic regression model for No SO state4 weeks

    Muscle Strength and Phase Angle Are Potential Markers for the Efficacy of Multidisciplinary Weight-Loss Program in Patients with Sarcopenic Obesity

    Journal of clinical medicine

Muscle mass

no changein humans1

1 study
  1. Multidisciplinary weight-loss program showed no clear effect on muscle mass in humans (sarcopenic obesity).

    “Muscle mass (MM) and SMMI remained unchanged in the studied cohort.”

    Human trialsarcopenic obesity4-weekn = 188

    Muscle Strength and Phase Angle Are Potential Markers for the Efficacy of Multidisciplinary Weight-Loss Program in Patients with Sarcopenic Obesity

    Journal of clinical medicine

More on Muscle mass

Liver transplant eligibility

upin humans1

1 study
  1. Multidisciplinary weight-loss program is linked with higher liver transplant eligibility in humans (high BMI liver transplant candidates) (8 transplanted and 4 waitlisted of 19 patients).

    “Eight patients received a transplant and 4 more patients were waitlisted.”

    Humanshigh BMI liver transplant candidatesn = 19

    Successful Implementation of a Multidisciplinary Weight Loss Program Including GLP1 Receptor Agonists for Liver Transplant Candidates With High Body Mass Index

    Transplantation

Body weight

downin humans1

1 study
  1. Multidisciplinary weight-loss program is linked with lower body weight in humans (high BMI liver transplant candidates) (median 11.7 kg (range 0-33)).

    “Median weight loss was 11.7 kg for all 19 patients (range, 0-33).”

    Humanshigh BMI liver transplant candidatesn = 19

    Successful Implementation of a Multidisciplinary Weight Loss Program Including GLP1 Receptor Agonists for Liver Transplant Candidates With High Body Mass Index

    Transplantation

What is multidisciplinary weight-loss program linked with?

1

Studies link multidisciplinary weight-loss program with sarcopenic obesity.

Sarcopenic obesity

downin humans1

1 study
  1. Multidisciplinary weight-loss program lowers the risk of sarcopenic obesity in patients with sarcopenic obesity at admission (42.6% (n = 80) out of 188 SO patients at admission resulted in not being sarcopenic).

    “At the end of the multidisciplinary program, 42.6% (n = 80) out of 188 SO patients at admission resulted in not being sarcopenic (No SO discharge), while for 108 patients, the SO condition was unchanged (SO discharge).”

    Human trialin patients with sarcopenic obesity at admission4 weeksn = 188

    Muscle Strength and Phase Angle Are Potential Markers for the Efficacy of Multidisciplinary Weight-Loss Program in Patients with Sarcopenic Obesity

    Journal of clinical medicine

  2. Multidisciplinary weight-loss program lowers the risk of sarcopenic obesity in humans (sarcopenic obesity) (42.55% (80 patients)).

    “At discharge, 80 patients (42.55%) were no longer classified as sarcopenic and showed significant improvements in HGS.”

    Human trialsarcopenic obesity4-weekn = 188

    Muscle Strength and Phase Angle Are Potential Markers for the Efficacy of Multidisciplinary Weight-Loss Program in Patients with Sarcopenic Obesity

    Journal of clinical medicine

More on Sarcopenic obesity

Latest